Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line

por Hashimoto, Yoshifumi, Macri, Daniel, Srivastava, Indresh, McPherson, Clifton, Felberbaum, Rachael, Post, Penny, Cox, Manon
Publicado 2017

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice

por Zhou, Zhimin, Post, Penny, Chubet, Rick, Holtz, Katherine, McPherson, Clifton, Petric, Martin, Cox, Manon
Publicado 2006

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant

por McPherson, Clifton, Chubet, Richard, Holtz, Kathy, Honda-Okubo, Yoshikazu, Barnard, Dale, Cox, Manon, Petrovsky, Nikolai
Publicado 2015

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability

por Feshchenko, Elena, Rhodes, David G, Felberbaum, Rachael, McPherson, Clifton, Rininger, Joseph A, Post, Penny, Cox, Manon MJ
Publicado 2012

Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss

por Holtz, Kathleen M, Robinson, Pamela S, Matthews, Erin E, Hashimoto, Yoshifumi, McPherson, Clifton E, Khramtsov, Nikolai, Reifler, Michael J, Meghrous, Jamal, Rhodes, David G, Cox, Manon M, Srivastava, Indresh K
Publicado 2014